Medicenna Therapeutics Corp. (MDNAF) Form 10-Q Quarterly Reports
Medicenna Therapeutics Corp. (MDNAF) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MDNAF
CIK: 1807983
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 03/31
State: Z4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 3/31/2021 12:00:00 AM
Lead Engagement PartnerNeil Rostant
Audit LocationOakville, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| D | 2026-07-06 | — | D Filing | 0001807983-26-000003 | View SEC Doc Filr Page |
| 15-12G | 2024-05-14 | — | FORM 15 | 0001171843-24-002865 | View SEC Doc Filr Page |
| D | 2024-05-14 | — | D Filing | 0001807983-24-000001 | View SEC Doc Filr Page |
| EFFECT | 2024-05-13 | — | EFFECT Filing | 9999999995-24-001503 | View SEC Doc Filr Page |
| 6-K | 2024-05-13 | 2024-05-13 | FORM 6-K | 0001171843-24-002798 | View SEC Doc Filr Page |
| SC 13G | 2024-05-10 | — | SC 13G | 0001104659-24-060023 | View SEC Doc Filr Page |
| POS AM | 2024-05-10 | — | POS AM | 0001171843-24-002763 | View SEC Doc Filr Page |
| 6-K | 2024-04-30 | 2024-04-30 | FORM 6-K | 0001104659-24-054880 | View SEC Doc Filr Page |
| 6-K | 2024-04-26 | 2024-04-26 | FORM 6-K | 0001104659-24-052859 | View SEC Doc Filr Page |
| 6-K | 2024-04-25 | 2024-04-24 | FORM 6-K | 0001171843-24-002233 | View SEC Doc Filr Page |
| AW | 2024-04-22 | — | FORM AW | 0001171843-24-002129 | View SEC Doc Filr Page |
| S-8 POS | 2024-04-16 | — | FORM S-8 POS | 0001171843-24-002034 | View SEC Doc Filr Page |
| F-3/A | 2024-04-16 | — | F-3/A | 0001171843-24-002033 | View SEC Doc Filr Page |
| F-10POS | 2024-04-16 | — | F-10POS | 0001171843-24-002032 | View SEC Doc Filr Page |
| 6-K | 2024-04-10 | 2024-04-09 | FORM 6-K | 0001171843-24-001936 | View SEC Doc Filr Page |
| 6-K | 2024-04-09 | 2024-04-09 | FORM 6-K | 0001171843-24-001924 | View SEC Doc Filr Page |
| 6-K | 2024-04-04 | 2024-04-04 | FORM 6-K | 0001171843-24-001834 | View SEC Doc Filr Page |
| 6-K | 2024-03-06 | 2024-03-06 | FORM 6-K | 0001171843-24-001208 | View SEC Doc Filr Page |
| SC 13G/A | 2024-02-21 | — | SC 13G/A | 0001104659-24-026196 | View SEC Doc Filr Page |
| 6-K | 2024-02-14 | 2023-12-31 | FORM 6-K | 0001171843-24-000779 | View SEC Doc Filr Page |
| 6-K | 2024-02-13 | 2024-02-13 | FORM 6-K | 0001171843-24-000739 | View SEC Doc Filr Page |
| SC 13G/A | 2024-02-07 | — | SC 13G/A Filing | 0001493152-24-005332 | View SEC Doc Filr Page |
| 6-K | 2024-01-24 | 2024-01-24 | FORM 6-K | 0001104659-24-006239 | View SEC Doc Filr Page |
| 6-K | 2024-01-16 | 2024-01-12 | FORM 6-K | 0001171843-24-000246 | View SEC Doc Filr Page |
| 6-K | 2024-01-09 | 2024-01-09 | FORM 6-K | 0001171843-24-000151 | View SEC Doc Filr Page |